United States · FDA National Drug Code directory
Haloperidol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0832-1520_ca5f7ae2-4c1e-488e-8d6f-32c3a5bfe3fb
- Product NDC
- 0832-1520
- Form
- TABLET
- Composition / generic term
- Haloperidol
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200109
- Source listing expiry
- 20271231
Source-listed ingredients
- HALOPERIDOL — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (0832-1520-01) / 1 TABLET in 1 BLISTER PACK (0832-1520-89) · 0832-1520-01
- 100 TABLET in 1 BOTTLE (0832-1520-11) · 0832-1520-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →